Skip to:


Cost-Effectiveness of a Potential Prophylactic Helicobacter pylori Vaccine in the United States.
Journal Article

Published By

Journal of Infectious Disease, Vol. 200

September 14, 2009

Background. Helicobacter pylori vaccines are under development to prevent infection. We quantified the cost‐effectiveness of such a vaccine in the United States, using a dynamic transmission model.

Share This Publication